Abstract 5000: Cell cycle checkpoint kinase (CHK)1 inhibition induces immune modulation in recurrentBRCAwild-type high-grade serous ovarian cancer (HGSOC) patients
Keyword(s):
Keyword(s):
2016 ◽
2014 ◽
Vol 289
(22)
◽
pp. 15319-15327
◽
Keyword(s):
Keyword(s):
2019 ◽
2020 ◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 93
(1)
◽
pp. 240-245
◽
Keyword(s):